Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 30, 2017

Poll Results
How likely would you be to support regulation aimed at restricting or limiting the sale of OTC loperamide?
  Very likely 20.2%
  Likely 16.3%
  Not likely 34.6%
  Very unlikely 28.8%

  Total # Taken: 104

Previous Polls
How likely would you be to recommend safinamide for a patient with Parkinson’s disease on levodopa/carbidopa with significant “off” periods?
Do you agree that a target blood pressure of 140/90 or less is appropriate for most low-risk patients less than 60 years of age?
How often have you encountered the new heart failure drug, ivabradine (Corlanor), as either non-formulary, or prior authorization only status?
How often have you counseled about potential long-term side effects and/or Black Box warnings with topical tacrolimus or pimecrolimus?
How often have you contacted a prescriber upon suspecting testosterone abuse in a patient?
How likely would you be to request that a physician change a prescription from EpiPen® to Adrenaclick® for a patient without insurance coverage?
How likely would you be to support regulation aimed at restricting or limiting the sale of OTC loperamide?
How likely are you to recommend a quinolone antibiotic for an adult patient with an upper respiratory tract infection?
How likely are you to recommend an SGLT-2 inhibitor in a patient with Type 2 diabetes with renal impairment?
How likely are you to recommend a systolic blood pressure target of < 120mmHg in a patient older than 50 with one cardiovascular risk factor?


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415